amiodarone has been researched along with Extravascular Hemolysis in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elhasi, S | 1 |
Astaneh, R | 1 |
Lavasanifar, A | 1 |
Hasan, T | 1 |
Kochevar, IE | 1 |
Abdulah, D | 1 |
2 other studies available for amiodarone and Extravascular Hemolysis
Article | Year |
---|---|
Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Chemical Precipitation; Chemistry, Pharmaceutical; Dela | 2007 |
Amiodarone phototoxicity to human erythrocytes and lymphocytes.
Topics: Amiodarone; Benzofurans; Cell Survival; Erythrocytes; Hemolysis; Humans; Lymphocytes; Ultraviolet Ra | 1984 |